Idera Pharmaceuticals (IDRA)
Idera Pharmaceuticals Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 0.009M | 0.008M | 0.004M | 0.033M | 0.008M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cost of Revenue | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Gross Profit | 0.009M | 0.008M | 0.004M | 0.033M | 0.008M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Research & Development Expense | 3.813M | 5.70M | 3.574M | 4.142M | 4.553M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 1.689M | 1.539M | 1.948M | 2.166M | 2.286M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 5.502M | 7.239M | 5.522M | 6.308M | 6.839M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -5.493M | -7.231M | -5.518M | -6.275M | -6.831M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | -1.393M | 2.071M | 0.029M | -0.007M | -0.014M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -6.886M | -5.16M | -5.489M | -6.282M | -6.845M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income after Tax | -6.886M | -5.16M | -5.489M | -6.282M | -6.845M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -6.886M | -5.16M | -5.489M | -6.282M | -6.845M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Income | -7.046M | -9.708M | -5.489M | -6.282M | -6.845M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 27.64 | 27.62 | 27.63 | 27.62 | 27.60 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 27.64 | 27.62 | 27.63 | 27.62 | 27.60 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.25 | -0.35 | -0.20 | -0.23 | -0.25 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.25 | -0.35 | -0.20 | -0.23 | -0.25 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
